z-logo
HomeZAIABlog
open-access-imgOpen Access
Tofacitinib
Author(s) -
Urspeter Masche
Publication year - 2014
Publication title -
pharma-kritik
Language(s) - German
Resource type - Journals
SCImago Journal Rank - 0.101
H-Index - 2
ISSN - 1010-5409
DOI - 10.37667/pk.2014.929
Subject(s) - gynecology , tofacitinib , medicine , rheumatoid arthritis
Mit Tofacitinib wird eine weitere biologische Substanz zur Basistherapie der rheumatoiden Arthritis angeboten. In anderen europäischen Ländern ist dieses oral verabreichbare Medikament wegen eines als ungünstig eingestuften Nutzen-Risiko-Verhältnisses bisher nicht zugelassen.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

AboutCareersPublisher PartnersContact UsGet Organisational Trial or Quote

Learn

FAQsBlogTerms of UsePrivacy Policy

Download the Zendy App

Get it on
Google Play
Download on the
App Store

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.